BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31846535)

  • 1. Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions.
    McCluggage WG
    Histopathology; 2020 Jan; 76(1):76-92. PubMed ID: 31846535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
    Kucera E; Hejda V; Dankovcik R; Valha P; Dudas M; Feyereisl J
    Eur J Gynaecol Oncol; 2011; 32(2):182-4. PubMed ID: 21614909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S
    Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
    Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
    Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pitfalls in the histopathological diagnostics of endometrial carcinoma and its precursors : Clinically relevant differential diagnoses, avoidance of false positive diagnoses].
    Kommoss F; Lax SF
    Pathologe; 2016 Nov; 37(6):512-520. PubMed ID: 27681950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrioid adenocarcinoma of the ovary arising in atypical endometriosis.
    Terada T
    Int J Clin Exp Pathol; 2012; 5(9):924-7. PubMed ID: 23119109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases.
    Yantiss RK; Clement PB; Young RH
    Am J Surg Pathol; 2000 Apr; 24(4):513-24. PubMed ID: 10757398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronously occurring endometrioid carcinomas of the uterine corpus and uterine cervix preceded by different precancerous lesions: A case study and a literature review.
    Monist M; Lewkowicz D; Piętak P; Pilewska-Kozak A; Man YG; Semczuk A
    Pathol Res Pract; 2023 May; 245():154452. PubMed ID: 37030165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometriosis-associated ovarian cancer: a clinicopathologic review.
    Steed H; Chapman W; Laframboise S
    J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sex cord-like variant of endometrioid adenocarcinoma arising from endometriosis.
    Kauppila S; Altinörs M; Väre P; Liakka A; Knuuti E; Nissi R
    APMIS; 2008 Sep; 116(9):842-5. PubMed ID: 19024607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometriosis-associated ovarian neoplasia.
    Matias-Guiu X; Stewart CJR
    Pathology; 2018 Feb; 50(2):190-204. PubMed ID: 29241974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.